Trial Profile
A Pilot Study of the Efficacy and Safety of Paroxetine Augmented With Risperidone, Valproate, Buspirone, Trazodone, or Thyroid Hormone in Adult Chinese Patients With Treatment-Resistant Major Depression
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 Sep 2011
Price :
$35
*
At a glance
- Drugs Mirtazapine (Primary) ; Paroxetine (Primary) ; Venlafaxine (Primary) ; Buspirone; Risperidone; Thyroid hormones; Trazodone; Valproic acid
- Indications Major depressive disorder
- Focus Therapeutic Use
- Acronyms OPERATION
- 05 Nov 2010 New trial record.